Notice2023-09548
Advisory Committee on Immunization Practices
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 5, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 87 (Friday, May 5, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 87 (Friday, May 5, 2023)]
[Notices]
[Pages 29132-29133]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-09548]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0035]
Advisory Committee on Immunization Practices
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Advisory Committee on Immunization Practices (ACIP). This
meeting is open to the public. Time will be available for public
comment.
DATES: The meeting will be held on June 21, 2023, 8 a.m. to 5:15 p.m.,
EDT, June 22, 2023, 8 a.m. to 5 p.m., EDT, and June 23, 2023, 8 a.m. to
1 p.m., EDT (times subject to change, see the ACIP website for updates:
<a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>).
Written comments must be received between June 5-16, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0035, by either of the methods listed below. CDC does not accept
comments by email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Ms. Stephanie Thomas, ACIP Meeting, Centers for
Disease Control and Prevention, 1600 Clifton Road NE, MS H24-8,
Atlanta, GA 30329-4027. Attn: Docket No. CDC-2023-0035.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the <a href="https://www.regulations.gov">https://www.regulations.gov</a> suitability policy will be posted
without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the ACIP website at <a href="https://www.cdc.gov/vaccines/acip/index.html">https://www.cdc.gov/vaccines/acip/index.html</a>.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management
Specialist, Advisory Committee on Immunization Practices, National
Center for Immunization and Respiratory Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-8836; Email: <a href="/cdn-cgi/l/email-protection#b4f5f7fde4f4d7d0d79ad3dbc2"><span class="__cf_email__" data-cfemail="0746444e574764636429606871">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee on Immunization Practices (ACIP) is
charged with advising the Director, Centers for Disease Control and
Prevention (CDC), on the use of immunizing agents. In addition, under
42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children Program (VFC), along with schedules regarding dosing
interval, dosage, and contraindications to administration of vaccines.
Further, under applicable provisions of the Affordable Care Act and
section 2713 of the Public Health Service Act, immunization
recommendations of ACIP that have been approved by the Director, CDC,
and appear on CDC immunization schedules generally must be covered by
applicable health plans.
Matters to be Considered: The agenda will include discussions on
Mpox vaccines, influenza vaccines, pneumococcal vaccines, meningococcal
vaccines, Polio vaccine, respiratory syncytial virus vaccine pediatric/
maternal, respiratory syncytial virus vaccine in older adults, dengue
vaccines, Chikungunya vaccine, informational session by CDC
Immunization Safety Office, and COVID-19 vaccines. Recommendation votes
on influenza vaccines, pneumococcal vaccines, Polio vaccines, and
respiratory syncytial virus vaccine in older adults are scheduled. A
VFC vote on pneumococcal vaccines is scheduled. Agenda items are
subject to change as priorities dictate. For more information on the
meeting agenda visit <a href="https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html">https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html</a>.
Meeting Information: The meeting will be webcast live via the World
Wide Web. For more information on ACIP, please visit the ACIP website:
<a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket. CDC does not accept comments by
email.
Written Public Comment: The docket will be opened to receive
written comments on June 5, 2023. Written comments must be received by
June 16, 2023.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Oral public comment will occur
before any scheduled votes including all votes relevant to the ACIP's
Affordable Care Act and Vaccines for Children Program roles. Priority
will be given to individuals who submit a request to make an oral
public comment before the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the June 21, 2023, ACIP meeting must submit a
request at <a href="http://www.cdc.gov/vaccines/acip/meetings/index.html">http://www.cdc.gov/vaccines/acip/meetings/index.html</a> no
later than 11:59 p.m., EDT, June 16, 2023, according to the
instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for the
[[Page 29133]]
scheduled public comment session. CDC staff will notify individuals
regarding their request to speak by email by June 20, 2023. To
accommodate the significant interest in participation in the oral
public comment session of ACIP meetings, each speaker will be limited
to three minutes, and each speaker may only speak once per meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-09548 Filed 5-4-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 5, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.